Press release
Global Transdermal Patch Market and Clinical Pipeline Outlook 2022 Report Download
“Global Transdermal Patch Market and Clinical Pipeline Outlook 2022” report discusses the ongoing clinical and non-clinical parameters with respect to development of global transdermal patch market. Report highlights the need for integration of transdermal patches in existing drug delivery methodology available to pharmaceutical companies. Currently there 40 transdermal patches available in the market and more than 70 patches are in clinical pipeline.“Global Transdermal Patch Market and Clinical Pipeline Outlook 2022” report highlights:
* Introduction and Classification of Transdermal Patch
* Mechanism of Transdermal Patch Drug Delivery
* Transdermal Patch v/s Traditional Drug Delivery Methods
* Global Transdermal Patch Clinical Pipeline Overview
* Marketed Transdermal Patch Clinical Insight by Company, Indication and Phase
* Global Transdermal Patch Market Future Prospects
Download Sample
For Report Sample Contact: neeraj@kuickresearch.com
Report Weblink: https://www.kuickresearch.com/report-global-transdermal-patch-market-and-clinical-pipeline-outlook-2022.php
Table of Contents
Introduction to Transdermal Patch
Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch
Why There Exist Need for Transdermal Patches?
Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of Transdermal Patch
4.3 Mechanism of Motion Sickness, Nicotine and Female Contraceptive Transdermal Patch
Transdermal Patch v/s Traditional Drug Delivery Methods
Global Transdermal Patch Market Outlook
6.1 Global Market Scenario
6.2 Regional Trends
Global Transdermal Patch Clinical Pipeline Overview
7.1 By Phase
7.2 By Region/Country
7.3 By Drug Class/Molecule
7.4 By Company
7.5 By Orphan and Fast Track Status
7.6 By Mode of Action
Global Transdermal Patch Market Dynamics
8.1 Favorable Market Parameters
8.2 Commercialization Challenges
Global Transdermal Patch Market Future Prospects
Global Transdermal Patch Clinical Insight
10.1 Unknown
10.2 Research
10.3 Preclinical
10.4 Clinical
10.5 Phase-I
10.6 Phase-I/II
10.7 Phase-II
10.8 Phase-II/III
10.9 Phase-III
10.10 Preregistration
10.11 Registered
Marketed Transdermal Patch Clinical Insight by Company, Indication and Phase
Competitive Landscape
12.1 3M Pharmaceuticals
12.2 Acrux
12.3 Agile Therapeutics
12.4 Allergan
12.5 ANI Pharmaceuticals
12.6 Antares Pharma
12.7 Bayer HealthCare Pharmaceuticals
12.8 Corium International
12.9 Chase Pharmaceuticals
12.10 DURECT Corporation
12.11 Endo Pharmaceuticals
12.12 Fempharm
12.13 Hisamitsu Pharmaceutical
12.14 Immune Pharmaceuticals
12.15 Imprimis Pharmaceuticals
12.16 Ipsen Bioscience
12.17 Johnson and Johnson
12.18 LaSalle Laboratories
12.19 Lavipharm-increase
12.20 MINRAD International
12.21 NeurogesX
12.22 Noven Pharmaceuticals
12.23 NuPathe
12.24 Nuvo Research
12.25 Novartis
12.26 Pain Therapeutics
12.27 ProStrakan
12.28 Purdue Pharma
12.29 Sanofi
12.30 Scilex Pharmaceuticals
12.31 Senju Pharmaceutical
12.32 Somerset Pharmaceuticals
12.33 Teikoku Seiyaku
12.34 Therapeutic Discovery Corporation
12.35 Transdermal Delivery Solutions Corp
12.36 UCB-full form
12.37 Xel Pharmaceuticals
12.38 Zosano Pharma
Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.
Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Transdermal Patch Market and Clinical Pipeline Outlook 2022 Report Download here
News-ID: 895058 • Views: …
More Releases from Kuick Resarch

Targeted Alpha Therapy Market
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights:
• Global Targeted Alpha Therapy Market Insight By Region
• Approved Targeted Alpha Therapy Dosage & Pricing Insight
• Number Of Targeted Alpha Therapy In Clinical Trials: > 20 Drugs
• Targeted Alpha Therapy Clinical Trials Insight By Company, Country, Indication & Phase
• Marketed Targeted Alpha Therapy Clinical Insight By Company, Country & Indication
• Targeted Alpha Therapy Proprietary Technology Platform Insights By…

Global Cancer Antibody Drug Conjugates Market
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions:
• Global Cancer Antibody Drug Conjugates Market: 2020 - 2030
• Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 Billion By 2030
• Approved Cancer Antibody Drug Conjugates: 16 Drugs
• Approved Cancer Antibody Drug Conjugates Sales Insights, Patent, Dosage and Price Analysis
• Cancer Antibody Drug Conjugates In Clinical Trials: > 500 Drugs
• Cancer Antibody Drug Conjugates Clinical…

Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…

Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,…
More Releases for Transdermal
Transdermal Skin Patches: Market Trends and Forecast
The transdermal skin patches market size has grown steadily in recent years. It will grow from $7.36 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, strong economic growth in emerging markets, the increase in pharmaceutical r&d expenditure and increased healthcare expenditure.
The transdermal skin patches…
Global Transdermal Drug Delivery Systems Market 2023 Industry Data - Transdermal …
Global Transdermal Drug Delivery Systems market report by The Brainy Insights provides readers with a descriptive outlook of the market at regional as well as country levels. The historical data in the report provides an accurate analysis of the market in the forecast period (2023-2032). Market was studied in-depth to provide an overview of the market by value chain analysis and SWOT analysis. The study was done by doing a qualitative and…
Global Transdermal Skin Patches Market | Global Transdermal Skin Patches Industr …
The transdermal skin patches market comprises of sales of transdermal skin patches products and connected services utilize to deliver medicine to the human body through patches. The Transdermal skin patches comprise the usage of adhesive patches made up of polymers that comprises drugs. The drug from such patches are absorbed into the body and ultimately into the blood stream disregarding the drug delivery through pill, or injections.
According to the…
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018…
US Transdermal Patch Market US Transdermal Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Transdermal Patch
2. Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch
3. Why There Exist Need for Transdermal Patches?
4. Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of…
Transdermal Patch Market Transdermal Patch Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Transdermal Patch
Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch
Why There Exist Need for Transdermal Patches?
Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of Transdermal Patch
4.3…